A two year postdoctoral position is available at Virginia Commonwealth University in the Chemical and Life Sciences Engineering Department. VCU, in collaboration with MIT, University of Washington and the Clinton Health Access Initiative, has received funding from the Gates foundation to undertake research to reduce the cost of medically important therapies which will impact health in lower income countries. This is a unique opportunity to expand your scientific skills and impact global health in a positive way.
The research project will involve redesigning and/or improving the preparation of these molecules using both chemistry, biocatalytic and/or chemical engineering techniques with the intent of cost reduction, and efficiency using the principals of green chemistry. Ultimately we envision moving these existing processes from the existing batch to more efficient chemical, biocatalytic and continuous flow manufacturing processes. This exciting opportunity will afford the opportunity to work and collaborate with MIT, the University of Washington, and the Clinton Health Access Initiative.
The successful applicant will need to be interested with mentoring and supporting graduate and undergraduate students and have the skills to do so, as well as work in collaboration with a larger and more diverse group of scientists working in the general field of Pharmaceutical Engineering.
Preferred Qualifications (a selection of these):
You will be joining the laboratory of Dr. Tom Roper who recently joined VCU after a 22 year career at GlaxoSmithKline Pharmaceuticals. Dr. Roper held senior positions in the Pharmaceutical Development Division of GSK, including responsibilities for Process R&D and Analytical development for API in the US, and most recently was the Global Head of Exploratory Development Sciences.